全球聚合物生医材料市场（按产品、应用和地区划分）

2025 年全球聚合物生医材料市场规模预计为 670.3 亿美元，预计到 2032 年将达到 1,687.6 亿美元，2025 年至 2032 年复合年增长率为 14.1%。

数字。 2025年全球市场占有率聚合物生医材料各地区市占率（%）

聚合物生医材料是用于医疗应用和医疗设备的生物相容性聚合物。由于其生物分解性和生物相容性，它们在组织工程和再生医学应用中发挥重要作用。聚合物生医材料包括胶原蛋白和弹性蛋白等天然聚合物，以及Polyglycolic(PGA)、聚乳酸 (PLA) 和聚己内酯 (PCL) 等合成聚合物。这些聚合物可调节的物理化学性质和降解行为使其成为药物传输载体、医疗植入和组织再生支架的有吸引力的候选材料。由于聚合物生物生医材料在心血管、整形外科、牙科和创伤治疗应用中的使用日益增多，全球聚合物生医材料市场正经历显着成长。

市场动态：

全球聚合物生医材料市场的主要驱动力是慢性病盛行率的上升、老年人口的增长以及医疗植入和组织工程程序的使用增加。根据联合国预测，到 2050 年，65 岁及以上人口将从 2020 年的 7.03 亿增加到 15 亿。人口老化预计将推动用于植入、组织支架和其他医疗应用的聚合物生医材料的需求。此外，具有可调降解特性、加工技术多功能性的新型生物可吸收聚合物的开发以及再生医学研究的不断增加也在推动市场成长。然而，严格的监管核准流程和高昂的研发成本可能会阻碍市场扩张。然而，新兴经济体医疗保健投资的不断增长和医疗技术的进步预计将在预测期内创造新的机会。

本研究的主要特点

• 本研究报告对全球聚合物生医材料市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
• 它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球聚合物生医材料市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球聚合物生医材料市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球聚合物生医材料市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 主要亮点
• 监管情景
• 近期动态
• PEST分析
• 波特分析
• 合併、收购和合作

4. 全球聚合物生医材料市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 全球聚合物生医材料市场（依产品划分），2020-2032

• 聚乳酸（PLA）
• Polyglycolic（PGA）
• 聚氨酯
• 聚四氟乙烯 (PTFE) 和膨体聚四氟乙烯 (ePTFE)
• 聚芳醚醚酮（PEEK）
• 氧环己酮聚合体（PDO）
• 其他的

6. 全球聚合物生医材料市场（按应用划分），2020-2032

• 心血管系统
• 生物可吸收支架
• 血管移植物
• 感应器
• 导管导引线
• 植入式心臟心臟去颤器
• 起搏器
• 其他的
• 牙科
• 组织再生材料
• 人工植牙
• 骨移植和骨替代物
• 齿片
• 牙科缝合线
• 其他的
• 整形外科
• 关节重建聚合物生物材料
• 组织固定产品
• 生物性骨材
• 关节内粘稠补充疗法
• 脊椎生物材料
• 其他的
• 整形外科
• 脸部除皱治疗
• 软组织填充剂
• 颅颜外科
• 生物工程皮肤
• 週边神经修復
• 去细胞真皮基质
• 其他的
• 神经病学
• 神经干细胞的封装
• 调车系统
• 用于中枢神经系统修復的水凝胶支架
• 皮质神经假体
• 其他的

7. 全球聚合物生医材料市场（按地区划分），2020-2032

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第八章竞争格局

• 公司简介
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc（Invibio Ltd.）
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation

第九章 章节

• 参考
• 调查方法
• 关于出版商

Global Polymeric Biomaterials Market is estimated to be valued at USD 67.03 Bn in 2025 and is expected to reach USD 168.76 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2032.

Figure. Global Polymeric Biomaterials Market Share (%), By Region 2025

Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.

Market Dynamics:

Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2020 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global polymeric biomaterials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global polymeric biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market

Detailed Segmentation:

• Global Polymeric Biomaterials Market, By Product
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polyurethanes
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Polyaryletheretherketone (PEEK)
  • Polydioxanone (PDO)
  • Others
• Global Polymeric Biomaterials Market, By Application
  • Cardiovascular
  • Bioresorbable Stents
  • Vascular Grafts
  • Sensors
  • Guidewires
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Others
  • Dental
  • Tissue Regeneration Materials
  • Dental Implants
  • Bone Grafts & Substitutes
  • Dental Membranes
  • Dental Sutures
  • Others
  • Orthopedic
  • Joint Replacement Polymeric Biomaterials
  • Tissue Fixation Products
  • Suture Anchors
  • Others
  • Orthobiologics
  • Viscosupplementation
  • Spine Biomaterials
  • Others
  • Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Sutures
  • Others
  • Bioengineered Skins
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
  • Neurology
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold For CNS Repair
  • Cortical Neural Prosthetics
  • Others
  • Others
• Global Polymeric Biomaterials Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Polymeric Biomaterials Market, By Product
  • Global Polymeric Biomaterials Market, By Application
  • Global Polymeric Biomaterials Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing orthopedic and dental applications
  • Stringent regulatory environment
  • Emerging markets in Asia Pacific and Latin America
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Polymeric Biomaterials Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Polymeric Biomaterials Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Polylactic Acid (PLA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyglycolic Acid (PGA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyurethanes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyaryletheretherketone (PEEK)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polydioxanone (PDO)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Polymeric Biomaterials Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bioresorbable Stents
• Vascular Grafts
• Sensors
• Guidewires
• Implantable Cardiac Defibrillators
• Pacemakers
• Others
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tissue Regeneration Materials
• Dental Implants
• Bone Grafts & Substitutes
• Dental Membranes
• Dental Sutures
• Others
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Joint Replacement Polymeric Biomaterials
• Tissue Fixation Products
  • Suture Anchors
  • Others
• Orthobiologics
• Viscosupplementation
• Spine Biomaterials
• Others
• Plastic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Facial Wrinkle Treatment
• Soft Tissue Fillers
• Craniofacial Surgery
  • Sutures
  • Others
• Bioengineered Skins
• Peripheral Nerve Repair
• Acellular Dermal Matrices
• Others
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neural Stem Cell Encapsulation
• Shunting Systems
• Hydrogel Scaffold For CNS Repair
• Cortical Neural Prosthetics
• Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Polymeric Biomaterials Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profile
  • Stryker
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
• Analyst Views

9. Section

• References
• Research Methodology
• About us